NCT06347705View on ClinicalTrials.gov

A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

March 28, 2029

Study Completion Date

March 28, 2029

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

2141-V11 Antibody

2141-V11 Antibody: Intratumor injection

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All protocol activites), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre

11725

RECRUITING

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack

07920

RECRUITING

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER